Barrett's metaplasia (BM) is an early lesion in the progression from oesophageal inflammation through dysplasia to the development of Barrett's adenocarcinoma (BA). Previous work indicates that BM and BA are associated with reduced E-cadherin expression and increased cytoplasmic/nuclear pools of its associated protein b-catenin. b-catenin participates in Wnt signalling and activates oncogene transcription by complexing with T-cells factors (TCF). One such oncogene is c-myc. We have previously shown that TNF-a can downregulate E-cadherin expression. Here, we assess TNF-a expression in Barrett's metaplasia and examine if TNF-a can promote b-catenin mediated transcription of oncogenes in a gastrointestinal model system. Employing immunohistochemistry and Western blot analysis of oesophageal tissue, epithelial expression of TNF-a increases with progression along the metaplasia -dysplasia -carcinoma sequence (P50.001). b-catenin mediated transcription was then assessed in TNF-a stimulated cell lines using the TOPFLASH reporter system whilst cmyc expression was assessed by real time PCR. In a columnar intestinal cell model, TNF-a induces c-myc expression which is induced via b-catenin mediated transcription (P50.05). This b-catenin mediated transcription is independent of NF-kB activation. Thus, TNF-a is up-regulated in the progression of Barrett's oesophagus and b-catenin mediated transcription of cmyc is a novel pathway whereby elevated levels of TNF-a may lead to oncogene transcription and altered biology in gastrointestinal epithelia and metaplasia.
Introduction
Population studies indicate that between 0.5 -2% of adults in the western world have Barrett's oesophagus (Cameron et al., 1991) . This may be defined as metaplasia of the distal oesophageal epithelium with a change from native stratified squamous epithelium to a columnar intestinal type mucosa (Sampliner, 1998) . The main interest in oesophageal metaplasia is that it is thought to give rise to most, if not all oesophageal and gastro-oesophageal junction adenocarcinomas (MenkePluymers et al., 1992) . In addition the UK has the highest conversion rate from Barrett's oesophagus to Barrett's adenocarcinoma (Jankowski et al., 2002) . The resulting adenocarcinoma is characterized by a uniformly poor prognosis, with a median survival time following diagnosis of less than 18 months, and a 5 year survival rate of less than 20% in operable tumours (Thomas et al., 1997) . The majority of BM (Barrett's metaplasia) is acquired in adult life arising principally as a result of gastro-oesophageal reflux disease, although any insult that causes distal oesophageal irritation, such as chemical injury, is also permissive for metaplasia (Dixon et al., 2001; Goldblum et al., 1998) . A common feature of acid and bile damage to the native oesophageal mucosa is a mixed inflammatory cell infiltrate especially around the stem cell rich areas of the basal mucosal compartment and papillae (Jankowski et al., 2000) .
Agents, which have been implicated in both inflammatory and malignant processes, include the cytokines TNF-a (Tumour Necrosis Factor-a) and IL1b (Interleukin 1-b) (Frommel and Zarling, 1999; ElOmar et al., 2000; Papadakis and Taragan, 2000) . TNF-a can be detected in malignant and/or stromal cells in ovarian, breast, prostate, bladder and colorectal cancers and TNF-a production appears to correlate with tumour progression or worsening prognosis in prostate cancer and haematogenous malignancies (Balkwill and Mantovani, 2001) . Confirmation of the importance of TNF-a in malignancy is derived from murine knockout studies where mice lacking the gene for TNF-a are resistant to skin carcinogenesis (Moore et al., 1999) . The mechanism of action of TNF-a in carcinogenesis is unclear. However TNF-a is a pro-inflammatory cytokine, which can have direct effects on epithelial cells or can regulate the production of other cytokines and metalloproteinases, which may promote tumour growth or metastasis (Cottam and Rees, 1993; Schmitz et al., 1999) .
Analysis of oesophageal adenocarcinomas has shown that tumour stage invasiveness is associated with reduced expression of the cell adhesion molecule and tumour suppressor E-cadherin (Bailey et al., 1998) . Ecadherin is a transmembrane protein that mediates cell -cell adhesion and is anchored to the actin cytoskeleton through the action of the multifunctional protein b-catenin (Kemler, 1993) . Loss of membranous b-catenin expression and an increase in cytoplasmic/ nuclear b-catenin localization is a common feature of oesophageal cancer (Bailey et al., 1998) . We have previously shown that cytokines including TNF-a can down-regulate the expression of E-cadherin and that this is mediated at a transcriptional level (Perry et al., 1999) . Levels of free cytosolic b-catenin, i.e. that which is not bound to E-cadherin at the membrane, are tightly regulated by a complex of APC (Adenomatous Polyposis Coli), Axin and GSK-3b (Glycogen Synthase Kinase-3 beta). Binding to this complex directs degradation of b-catenin by the ubiquitination pathway. Cytoplasmic b-catenin that is not degraded can bind to nuclear transcription factors of the TCF (T-cell factor) family, and consequently translocate into the nucleus (Polakis, 1999; Ben-Ze'ev and Geiger, 1998) . Moreover b-catenin/TCF complexes have been shown to promote transcription of many known target genes including several oncogenes such as c-myc and Cyclin D1 (Mann et al., 1999; Tetsu and McCormick, 1999) . Hence, any aberrance in the degradation of b-catenin can ultimately cause an increase in oncogene activation.
Here we explore the hypothesis that levels of TNF-a are elevated during the progression of Barrett's oesophagus. We then examine the hypothesis that TNF-a can regulate the level of b-catenin mediated oncogene transcription in gastrointestinal cell models.
Results

Expression of TNF-a in Barrett's metaplasia and adenocarcinoma
Immunohistochemical assessment of TNF-a expression is shown in Figure 1 and Table 1 . This demonstrates an absence of TNF-a expression in control normal gastric mucosa ( Figure 1a ) and very low levels of expression in normal oesophageal squamous mucosa (Figure 1b) . Expression of TNF-a does not increase in benign oesophagitis compared with normal squamous oesophagus. However, the chronic inflammation in nondysplastic BM is characterized by increased TNF-a immunoreactivity in the lamina propria lymphocytes and in the epithelial cells of deeper glands of the mucosa when compared with normal squamous mucosa ( Figure 1c) . Epithelial TNF-a expression is stronger in the regions of the mucosa where the lymphoid infiltrate was most conspicuous, i.e. in the mid/lower lamina propria. Interestingly, these latter regions of the Barrett's glands are where the metaplastic stem cells are located. BM progresses through a sequence from non-dysplastic to dysplastic metaplasia before becoming overtly malignant. Immunoreactivity in dysplastic tissue is of a greater intensity and more widespread than in non-dysplastic metaplasia with this increase being localized specificially to the epithelial cells displaying marked dysplastic changes of large and prominent nuclei (Figure 1d,e) . In Barrett's adenocarcinoma, most tumour cells express TNF-a (Figure 1f) . Thus both the distribution and intensity of immunoreactivity for TNF-a increased in sections from progressively later stages of the metaplasia -dysplasiacarcinoma sequence.
In 74 of the 85 cases of Barrett's adenocarcinoma patient survival data was available. TNF-a expression was positive in 73% of these cases (54/74 positive). There was no survival advantage or disadvantage associated with TNF-a expression (P=0.1).
TNFR1 expression was also assessed by immunohistochemistry (Figure 2 ). This demonstrates that TNFR1 expression is enhanced along the progression of Barrett's oesophagus to adenocarcinoma in a similar manner to that of TNF-a. These immunohistochemistry observations were further confirmed by Western blot analysis (Figure 3) .
If TNF-a is to regulate the level of b-catenin mediated oncogene transcription then it would be sensible to expect that expression of TNF-a coincided with changes in b-catenin localization within the tissue sections. This was assessed using immunofluorescence microscopy. Figure 4a demonstrates that in an area of Barrett's metaplasia where TNF-a is not expressed bcatenin remains preserved at the cell borders. However, where TNF-a is expressed the localization of b-catenin is now cytoplasmic/nuclear. Furthermore in these areas there was also evidence of c-myc expression ( Figure  4b ), a known target of b-catenin/Tcf signalling.
TNF-a stimulation of epithelial cell lines: c-myc transcription
In order to test the hypothesis that elevated levels of TNF-a may contribute to oncogenesis in gastrointestinal epithelium we assessed the degree of c-myc (an archetypal oncogene) gene transcription. This was determined using a Real Time PCR strategy employing three columnar type (OE33E, oesophageal adenocarcinoma, SW480, colorectal adenocarcinoma, and Caco-2, colorectal adenocarcinoma) and three squamous type (oesophageal squamous cell carcinoma OE21E, TE1 and TE2) cell lines following 0 -48 h stimulation with TNF-a ( Figure 5) .
A significant increase in c-myc transcription following TNF-a exogenous stimulation was seen in all three columnar type cell lines. This was characterized by a rapid increase, with maximal induction (3 -15-fold) at 3 h, with Caco-2 cells demonstrating the most marked response. This was in contrast to the three squamous cell lines, in which a very modest 50% increase in transcription was observed at 1 h, with the response terminating rapidly.
TNF-a stimulation induces b-catenin mediated transcription
c-myc is a target gene of b-catenin mediated transcription. Therefore in order to determine if this induction of c-myc was indeed regulated by this pathway, we Figure 3 Western blot analysis of TNF-a, TNF-a receptor 1 in the progression of Barrett's metaplasia to adenocarcinoma. TNF-a has a molecular weight of 18.5 kDa, TNFR1 has a molecular weight of 55 kDa and the epithelial loading control was epithelial specific antigen (ESA) with a molecular weight of 40 kDa. This blot is representative of the findings from specimens of normal squamous mucosa (S), Barrett's metaplasia (B) and Barrett's adenocarcinoma (ADC) utilized the TOPFLASH reporter system. Caco-2 cells were specifically chosen as this cell line demonstrated the greatest response to TNF-a. Catenin mediated transcription was assessed in TNF-a stimulated cells, compared with cells which had been transfected with wild type Adenomatous Polyposis Coli gene (APC) 24 h prior to TNF-a stimulation, and cells transfected with APC alone (Figure 6a ). This demonstrated a significant 2.3+0.3-fold increase in catenin mediated transcription following TNF-a stimulation compared with unstimulated controls (P50.05). In addition transfection of APC, eliminated the TNF-a response (P50.05) whereas transfection with APC alone had no effect. This was further substantiated by preparing nuclear preparations of the cells before and stimulation with TNF-a. Following TNF-a stimulation there was a marked increase in nuclear b-catenin levels and furthermore this could be suppressed in the presence of exogenously transfected APC ( Figure 6b ).
Thus TNF-a, a stimulus that induces c-myc transcription can induce an elevation in nuclear b-catenin levels and b-catenin mediated transcription, both of which can be inhibited by wild type APC in Caco-2 cells. Pathways involved in TNF-a induction of b-catenin mediated transcription TNF-a signalling occurs through several intracellular pathways including NF-kB (Nuclear factor kB) activation and initiation of the MAPK (Mitogen activated protein kinase) cascade that includes ERK (Extracellular signal regulated kinase) and p38 activation. Caco-2 cells were pre-incubated for 1 h with either 50 mM PD 98059 which inhibits ERK activation, or 20 mM SB 203580 which inhibits p38 kinase activation or 50 mM Bay-11-7082 which inhibits nuclear translocation of NF-kB, prior to stimulation with TNF-a and assessment using the TOPFLASH system. Control experiments with unstimulated cells in the absence of inhibitor or with 1 h pre-incubation with each inhibitor alone were performed (Figure 7a ).
This confirms the increase in b-catenin mediated transcription following TNF-a stimulation, which is completely abrogated by pre-stimulation with either p38 or ERK inhibitors. p38 and ERK inhibitors have no effect on unstimulated cells. Thus TNF-a stimulation increased catenin mediated transcription and this occurs through the p38 and ERK pathways. Preincubation with the NF-kB inhibitor induces an increase in b-catenin mediated transcription in both unstimulated and stimulated cells. Thus b-cateninmediated transcription is not mediated by NF-kB, indeed NF-kB activation may be opposing the response in both resting and TNF-a stimulated cells, inhibition of which induces an increase in transcription. We have further confirmed that TNF-a is inducing NF-kB by use of an NF-kB reporter construct and that Bay-11 completely abolishes this response at 1 h post stimulation (Figure 7b ). To further rule out an involvement of NF-kB in mediating catenin transcription we have utilized a dominant negative IkB construct. Transfection of cells with dominant negative IkB did not suppress the induction in catenin-regulated transcription following TNF-a stimulation (Figure 7a ).
c-myc gene transcription: a result of b-catenin mediated transcription
The elevation in b-catenin mediated transcription following TNF-a stimulation may be responsible for the increase in c-myc transcription that is seen following TNF-a stimulation. In order to test this hypothesis, levels of cmyc transcription were assessed in Caco-2 cells using a real time PCR strategy and the b-catenin pathway was modulated. c-myc transcription was determined in TNF-a stimulated cells, cells that had been transfected with wild (Figure 8a ). This demonstrated a significant 12-fold increase in c-myc transcription following TNF-a stimulation (P50.05). This was prevented by transfection of APC, which inhibits bcatenin mediated transcription. Furthermore, we have shown the same c-myc pattern of expression in response to TNF-a and APC in the oesophageal cell line OE33 ( Figure  8b ). Thus in these cell systems TNF-a induces c-myc transcription through a b-catenin mediated process.
TNF-a induced proliferation
In order to assess whether the increased level of c-myc in the TNF-a stimulated cells was having a biological effect we assessed proliferation and cell survival by FACS analysis. FACS analysis indicated that there was an elevation of cells in S phase following TNF-a stimulation from 46 to 61% (P50.05) (Figure 9 ). Moreover, this induction of proliferation following stimulation was repressed back to basal proliferation when Caco-2 cells were transfected with exogenous full length APC prior to TNF-a stimulation. No changes were observed in cell survival.
Discussion
The protein expression data presented here demonstrates that TNF-a, which is only observed at very low Figure 7 Inhibition of TNF-a signalling pathways that induce b-catenin mediated transcription. (a) Caco-2 cells were pre-incubated for 1 h with one of the following inhibitors: 50 mM PD 98059 which inhibits ERK activation (PD); 20 mM SB 203580 which inhibits p38 kinase activation (SB); 50 mM Bay-11-7082 which inhibits nuclear translocation of NF-kB (Bay); 1 mmol IkB (IkB) 24 h prior to stimulation with TNF-a. Cells were then transfected with TOPFLASH and a b-Galactosidase construct. Control experiments with unstimulated cells in the absence of inhibitor or with 1 h pre-incubation with each inhibitor alone are also shown. Results are expressed as a Luciferase/Galactosidase ratio (Lucif/Gal) and are shown relative to that of unstimulated cells. Data is the mean of at least three experiments +2 s.e.m.; *=significant at P50.05 comparing stimulated with unstimulated cells; $=significant at P50.05 comparing stimulated with stimulated/pre-inhibited group. (b) NF-kB activation was assessed using a luciferase reporter construct. Post confluent Caco-2 cells were stimulated with TNF-a for 1 to 8 h, alone (solid line) or with exposure to 50 mM Bay-11-7082 (dotted line) (Bay-11-7082 was applied as both a 1 h pre-incubation prior to cytokine stimulation and as continuing exposure during the cytokine stimulation). Cells were then transfected with both an NF-kB and a b-galactosidase construct. Data is the mean +2 s.e.m. of at least three results and is expressed as a Luciferase/Galactosidase ratio (Lucif/Gal), shown relative to that of unstimulated cells. This is a measure of NF-kB activation. The NF-kB reporter assay indicates that TNF-a induced NF-kB. In addition this TNF-a stimulation could be inhibited by IkB transfection TNF-a in Barrett's oesophagus C Tselepis et al levels in the basal compartment of normal squamous epithelium, was present at markedly elevated levels in Barrett's metaplastic tissue. It was of interest that epithelial TNF-a expression persisted and intensified in sections at later stages during the progression of Barrett's oesophagus to adenocarcinoma. In particular even within individual glands, it is the most dysplastic cells, which express TNF-a. Therefore, the degree of TNF-a expression increased along the metaplasiadysplasia -carcinoma sequence suggesting a relatively early role for TNF-a in the evolution of adenocarcinoma. Furthermore we demonstrated that the TNFR1 cytokine receptor was also increased in abundance during progression of disease thus potentially amplifying the TNF-a signal. Although we recognize that the survival data is somewhat limited, it does lend tentative support for an early role for TNF-a in the progression of Barrett's oesophagus. There is no survival difference in patients with tumours between those who express TNF-a and those who do not. This indicates that once a tumour is established the presence or absence of TNF-a does not at least in this study influence survival. However more functional studies, perhaps using monoclonal anti-TNF-a antibodies, and prospective immunohistochemical studies with many years followup of dysplastic patients will be required to further delineate the exact point of the metaplasia -dysplasiacarcinoma sequence that TNF-a influences.
In the early lesion of metaplasia, epithelial TNF-a immunoreactivity was most pronounced in regions where the lymphocytic infiltrate was most intense. This raises the possibility that epithelial cells, which under normal conditions produce very little or no TNF-a are stimulated to produce TNF-a by the chronic inflammatory cell infiltrate. Our data topographically supports the notion that lamina propria lymphocytes Figure 9 Assessment of TNF-a stimulated Caco-2 cell proliferation by FACs analysis. The y-axis represents cell counts (number), the x-axis DNA content of cells as they progress along the cell-cycle in the first growth phase (G 1 ), synthetic phase (S) and second growth phase (G2), respectively. K represents cellular debris and J is a calibration marker induce epithelial cell expression of TNF-a, at least in non-dysplastic BM. Support for this contention may be derived from recent studies by Haller et al. (2000) who utilized co-cultures of post confluent Caco-2 cells and human PBMC (Peripheral Blood Leucocytes). They assessed the response to Caco-2 cells to a noxious stimulus (bacterial contamination) and demonstrated that Caco-2 cells only expressed and secreted TNF-a in the presence of PBMC and that the cross talk between the two cell types was mediated by soluble factors, and that one of the most significant of these factors was TNF-a itself.
The mechanisms underpinning the role of TNF-a in the development and progression of malignancy are now the topic of much interest (Balkwill and Mantovani, 2001) . We have previously shown that TNF-a can reduce E-cadherin expression, a common feature of epithelial malignancy including that of Barrett's adenocarcinoma (Bailey et al., 1998; Perry et al., 1999; Birchmeier and Behrens, 1994) . Furthermore decreased membranous E-cadherin is associated with nuclear translocation of b-catenin in the progression of Barrett's cancer (Bailey et al., 1998; Perry et al., 1999) . Hence, it is plausible that these two simultaneous events of altered catenin and cadherin biology may be directed by TNF-a. Here we addressed the hypothesis that TNF-a may induce the transcription of the potent oncogene c-myc, and that this occurs through the b-catenin mediated transcription system.
In order to test such a hypothesis we used a range of cell lines including oesophageal tumour (adenocarcinoma and squamous) and colonic cell lines. Colonic Caco-2 cells were selected because, in the post confluent state, they differentiate into small intestinal-like enterocytes to such an extent that they are widely used as a model system in studies examining disease and function of the small intestine, since no reliable human small intestinal cell system is currently available (Perry et al., 1999) . It was important to have cells of small intestinal phenotype since it is the intestinal type metaplasia of the oesophagus that confers the cancer risk of Barrett's oesophagus. We were able however to validate these observations in the OE33(E) cell line which is derived from a purified welldifferentiated adenocarcinoma.
Our data indicates that TNF-a stimulation does induce c-myc transcription in intestinal epithelial cells. This occurs to a much greater degree in columnar adenocarcinoma cells compared with squamous cells.
In addition it appears that c-myc can be induced via TNF-a regardless of APC status since Caco-2 cells have an APC truncating mutation whereas the other two columnar cell lines have wild-type APC. This may suggest that the metaplastic columnar cells are more likely to be susceptible to the induction of c-myc by TNF-a than their squamous counterparts. The exact mechanism is not fully elucidated because all cell lines expressed the TNFR1. Of these columnar cells, the response was most marked in Caco-2 cells and thus we explored this phenomenon further in this cell line. cmyc transduction can be induced by several mechanisms such as via the NF-kB cascade, or as a target of the b-catenin system (Mann et al., 1999; Ji et al., 1994; Dang et al., 1999) . We demonstrate that TNF-a induction of c-myc is inhibited by exogenous transfection of full length APC, indicating that c-myc is probably regulated through the b-catenin system in this cell line. Furthermore using the TOFLASH system we demonstrate that TNF-a activates b-catenin mediated transcription, and that this occurs through a MAPK (p38 and ERK) dependent pathway and is not dependent on NF-kB. Although not directly germane it is important to emphasise that basal levels of c-myc expression in these cells are probably independent of TNF-a. FACS analysis demonstrated that TNF-a stimulation led to an increase in cell proliferation, and this again was inhibited by APC transfection implying that a target of b-catenin-mediated transcription was responsible.
b-catenin mediated transcription may be activated by several mechanisms such as loss of APC (Nathke, 1999) , loss of E-cadherin (Eger et al., 2000) , or tyrosine phosphorylation of b-catenin through the EGFR (Hoschuetzky et al., 1994) . We have previously shown that TNF-a may induce repression of E-cadherin in Caco-2 cells and Murthy et al. (2000) have also shown that TNF-a can induce ligand dependent and independent activation of the EGFR (Epidermal Growth Factor Receptor) (Perry et al., 1999; Murthy et al., 2000) . Thus, there are at least two substantiated mechanisms whereby TNF-a could initiate b-catenin mediated transcription of c-myc in this system. Thus in this system TNF-a appears to switch on bcatenin mediated oncogene transcription. This is via the MAPK system and independent of NF-kB, although the mechanism by which this occurs remains speculative. This process clearly increases transcription of c-myc and it will be of interest in the future to assess the transcription and expression of other b-catenin related oncogenes, such as Cyclin D1, as well as delineating the mechanism by which TNF-a activates b-catenin mediated oncogenesis. Thus this study raises as many questions as it addresses. However, despite this we have demonstrated a novel-signalling pathway for oncogene activation by cytokines.
We have presented data to show that TNF-a and TNFR1 expression is up-regulated in the progression of Barrett's metaplasia to adenocarcinoma. Furthermore, in our in vitro model TNF-a is able to induce transcription of the oncogene c-myc via a b-catenin mediated pathway that is independent of NF-kB. This is a novel mechanism whereby inflammatory cytokines can induce oncogene expression in gastrointestinal epithelial cells. This may be both relevant to Barrett's oesophagus and to other inflammatory states associated with oncogenesis.
Materials and methods
Immunocytochemistry
Blocks of formalin-fixed, paraffin-embedded tissue were selected from the pathology archives of the University TNF-a in Barrett's oesophagus C Tselepis et al
Hospital, Birmingham and of the Oesophageal Research Laboratory, Birmingham Heartlands Hospital. Specimens were examined by two independent gastrointestinal pathologists before inclusion in this study applying standard histological criteria. Cases were as follows: Normal squamous epithelium (n=20), inflamed squamous epithelium (n=20), Barrett's intestinal metaplasia (n=40), Barrett's dysplasia (n=20), Barrett's adenocarcinoma (n=85), normal gastric epithelium (n=20). Four mm sections were cut and mounted on Vectabond (Vector Laboratories, UK) coated glass slides for immunohistochemistry. Sections were dewaxed prior to proteolysis with 0.05% trypsin, following which they underwent microwave antigen retrieval in 0.01 M Tri-sodium citrate buffer, pH 6. Primary antibodies (Monoclonal anti-human TNF-a, 0.01 mg/ml; Autogen Bioclear or polyclonal anti-TNFR1 (Tumour Necrosis Factor Receptor), 0.01 mg/ml; R&D Systems) was applied to sections and incubated overnight at room temperature prior to thorough washing and detection by the avidin-biotinylated secondary antibody method (DAKO ABC kit) prior to visualization with DAB (diaminobenzidine) reagent. Controls included tonsil tissue as positive control, and omission of primary antibody as a negative control. Stained sections were assessed with regard to the intensity of epithelial staining (0, +, ++), and were scored independently by two observers (R Harrison and JAZ Jankowski).
Immunofluorescence on paraffin embedded sections . Sections were then extensively washed with PBS, incubated with 4',6-Diamidino-3-phenylindol dihydrochloride hydrate (DAPI) (1 : 10 000) for 1 min prior to mounting and visualization. Omission of primary antibodies was employed as a negative control.
Nuclear extraction
Cultured cells were washed and scraped into PBS followed by centrifugation for 10 min at 3000 r.p.m. Pelleted cells were resuspended in hypotonic buffer containing: 10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.2 mM PMSF, 0.5 mM DTT and allowed to swell for 10 min on ice. Cells were then transferred to a Dounce homogenizer and subjected to 10 strokes, followed by centrifugation for 15 min at 4000 r.p.m. The pellet was then resuspended in CASC buffer containing 93 mM Citric acid, 7 mM sodium citrate pH 2.6 and incubated for 30 min on ice, followed by centrifugation for 15 min at 4000 r.p.m. Nuclei were then resuspended in 100 ml nuclear extraction buffer containing 20 mM HEPES (pH 7.9), 400 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF and incubated on ice for 15 min, followed by centrifugation for 5 min at 13 000 r.p.m. The supernatant was then subject to a protein assay (Bio-Rad Protein assay) and an equal amount of protein loaded onto an 8% SDS -PAGE gel. In order to assess for any spurious cytoplasmic and membranous proteins we assessed Ecadherin levels (absence of this ubiquitous protein indicates pure nuclear preparations).
Western blotting
Tissue samples were collected from 10 normal oesophagus, 10 Barrett's metaplasia and 10 Barrett's adenocarcinomas. Fresh tissue biopsies were homogenized into loading sample buffer and 50 ng of protein samples were loaded on 8% SDS -PAGE gels. Following electrophoresis, gels were transferred onto Hybond membranes (Amersham-Pharmacia), blocked with 10% skimmed milk and incubated in either a goat polyclonal TNFR1 antibody (1 mg/ml; AF225, R&D Systems) or a rabbit polyclonal TNF-a antibody (5 mg/ml; CY 007, Immunogenetics). After extensive washing, membranes were incubated with the respective secondary horseradish peroxidase-conjugated antibody (Amersham Pharmacia) at a dilution of 1 : 10 000 (50 ng/ml). The membranes were then repeatedly washed and immunoreactive bands detected by the ECL detection system (Amersham Pharmacia). To normalize for epithelial loading we utilized the ubiquitous epithelial epitope, which is selectively bound by the monoclonal antibody, epithelial surface antigen (0.5 mg/ml; Novocastra) in order to correct sample bias accordingly. Positive controls used for TNF-a and TNFR1 were human recombinant TNF-a (Peprotech, UK) and MCF-7 cell lysate respectively; omission of primary antibody was employed as negative control. Western blots of nuclear preparations were processed as above with the exception of use of either a monoclonal E-cadherin antibody (Transduction Laboratories, 1 : 2000) or a monoclonal b-catenin antibody (Transduction Laboratories, 1 : 1000). Caco-2 and L929 cell lysates acted as positive and negative controls respectively for both antibodies.
Cell culture
Cell lines OE21(E) purified for epithelial phenotype, parent cell line derived from moderately differentiated oesophageal squamous cancer OE21 (Rockett et al., 1997) , TE1 and TE2 (both moderately differentiated oesophageal squamous cancer, Nishihira et al., 1993) , OE33(E) purified for epithelial phenotype, parent cell line derived from moderately well differentiated oesophageal adenocarcinoma OE33 (Rockett et al., 1997) , Caco-2 (well differentiated adenocarcinoma colonic cell line) and SW-480 (poorly differentiated colonic cell line) were all routinely maintained in Dulbecco's modified eagle's medium with 10% calf serum supplemented with 100 u/ml pencillin and 0.1 mg/ml streptomycin. A dose response curve for the biological effect of TNF-a on epithelial cells was performed and 50 ng/ml was identified as the optimal dose for stimulation experiments (Perry et al., 1999) .
Plasmids for transfection
TOPFLASH, a reporter plasmid containing a luciferase gene linked to a c-fos promoter under the control of multimeric consensus-TCF binding site that is only active in the presence of b-catenin, and thus is a measure of b-catenin mediated transcription; a kind gift from Hans Clevers (University Hospital Utrecht, Utrecht, The Netherlands) (van de Wetering et al., 1997) . A previously described b-galactosidase reporter construct was also used to normalize for transfection efficiency (Eliopoulos et al., 1997) . A full length APC construct was obtained as a kind gift from Professor B Vogelstein (Johns Hopkins Oncology Center, Baltimore, MD, USA). Both the NF-kB construct and the dominant negative IkB (pcMIkBa) construct were kind gifts from A Eliopoulos (Institute of Cancer Studies, Birmingham UK) and have been described previously (Eliopoulos et al., 1997) . In all experiments a transfection efficiency of at least 30% was achieved.
TNF-a stimulation: assessment of b-catenin/TCF mediated transcription TNF-a stimulation (50 ng/ml) of Caco-2 cells were performed in six well plates prior to transfection, with 1.5 mg of TOPFLASH and 3 mg of the b-galactosidase construct utilizing Lipofectamine lipid transfection agent according to manufacturers instructions (Life Technologies). At 48 h post transfection, expression of the reporter (luciferase reporter pconAluc; 3 HIV kB domains linked to fly luciferase gift of A Eliopoulos) and control (b-galactosidase) expression were determined using enzyme assay systems as previously described (Eliopoulos et al., 1997) . Results are expressed as a ratio of luciferase/galactosidase. Inhibitor studies were performed in which the cells were pre-incubated for 1 h with the appropriate inhibitor (either 50 mM PD 98059 Erk inhibitor, 20 mM SB 203580 p38 inhibitor, 20 mM or Bay-11-7082 NF-kB, inhibitor; all from Calbiochem, UK) prior to TNF-a stimulation. In the case of the dominant negative IkB construct, plasmid transfection was performed 24 h prior to TNF-a stimulation. Inhibition of the appropriate signalling cascade was confirmed by separate experiments assessing the effects of TNF-a and the respective inhibitor using either a transfected NF-kB reporter system or Western blots of phospho ERK or phospho p38 (data not shown). Transient APC transfection was performed with 4.5 mg of plasmid using Lipofectamine 24 h prior to TNF-a stimulation, APC protein production was confirmed by immunofluorescence. All experiments were performed in triplicate.
Real time PCR
RNA was harvested from cells using Trizol reagent according to manufacturer's instructions (GIBCO). One mg of RNA was then subject to reverse transcription using a cDNA reverse transcription kit (Promega, according to manufacturer's instructions). All reactions were performed on a real time PCR machine PE7700 (ABI Prism) using 18S ribosomal RNA as an internal standard (PE Biosystems, Roche, USA). Negative controls included samples with no RNA or control plasmid cDNA. Gene specific primers were synthesized by MWG-Biotech UK, and gene specific probes were synthesized by PE Biosystems. Each reaction was replicated three times on three separate runs and contained 900 nM of c-myc specific 5'-TCAAGAGGTGCCACGTCTCC and 3'-TCTTGGCAG-CAGGATAGTCCTT primers, 16 Mastermix (containing pre-optimized dNTP, MgCl 2 and buffer concentrations; PE Biosystems), 125 nM c-myc specific probe (5'-FAM-CAGCA-CAACTACGCAGCGCCTCC-TAMRA-3'), 50 nM 18 S 5' and 3' primers and 200 nM 18 S probe (5'-VIC, 3'-TAMRA labelled) and 0.25 ml of cDNA (equivalent to 12.5 ng of reverse transcribed RNA) in a 25 ml reaction.
Cycle ) were trypsinized, washed several times in PBS, resuspended in 200 ml PBS, and diluted to 1 ml with ethanol. Cells were left at room temperature for 30 min, washed several times in PBS, and resuspended in 0.1 mg/ml propidium iodide. To ensure that batch-to-batch variation did not perturb experiments, control cells with known cell cycling parameters were stained with propidium iodide and were used to calibrate the baseline. A minimum of 100 000 cells were then analysed using a Coulter XL FACS sorter. In particular numbers of cells in G1, S, G2 and M phases of the cell-cycle were assessed and expressed as a percentage of total cells.
Statistical analysis
Mantel -Haenszel chi-squared test for trend analysis was applied to the immunohistochemistry derived data to compare the degree of TNF-a expression between each subgroup. Standard log-rank test was used to determine if a survival advantage existed between TNF-a expressing and non TNF-a expressing sub-groups.
Mann -Whitney U tests were used to compare the degree of b-catenin mediated transcription (as expressed as luciferase/galactosidase ratios) between stimulated and unstimulated cells. Two-tailed tests were employed using SPSS version 9.0 (SPSS Inc, Chicago, IL, USA) and significance was accepted at the 5% level.
